Literature DB >> 18042688

Non-operative breast pathology: apocrine lesions.

C A Wells1, G A El-Ayat.   

Abstract

Apocrine metaplasia is a very common finding in the female breast after the age of 25. It is so common that many people regard it as a normal component of the breast. This, however, is only really the case in apocrine sweat glands of the axilla and in the peri-areolar apocrine glands. The apocrine cell does, however, contribute to a number of different breast lesions, some of which are very taxing diagnostically; apocrine variants of both in-situ and invasive cancer are encountered. This review considers the common apocrine metaplastic lesions seen in fibrocystic change as well as apocrine adenoma, apocrine change within sclerosing adenosis, atypical apocrine lesions and apocrine malignancies.

Entities:  

Mesh:

Year:  2007        PMID: 18042688      PMCID: PMC2095572          DOI: 10.1136/jcp.2006.040626

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  53 in total

Review 1.  The spectrum of apocrine lesions of the breast.

Authors:  F P O'Malley; A L Bane
Journal:  Adv Anat Pathol       Date:  2004-01       Impact factor: 3.875

Review 2.  Review of GCDFP-15. An apocrine marker protein.

Authors:  D E Haagensen; W G Dilley; G Mazoujian; S A Wells
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

3.  Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.

Authors:  G Mazoujian; G S Pinkus; S Davis; D E Haagensen
Journal:  Am J Pathol       Date:  1983-02       Impact factor: 4.307

4.  Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.

Authors:  A A Selim; G El-Ayat; C A Wells
Journal:  Histopathology       Date:  2001-08       Impact factor: 5.087

5.  Using biological measurements, can patients with benign breast disease who are at high risk for breast cancer be identified?

Authors:  W R Miller; W N Scott; W H Harris; D Wang
Journal:  Cancer Detect Prev       Date:  1992

6.  Long-term risk of breast cancer in women with fibroadenoma.

Authors:  W D Dupont; D L Page; F F Parl; C L Vnencak-Jones; W D Plummer; M S Rados; P A Schuyler
Journal:  N Engl J Med       Date:  1994-07-07       Impact factor: 91.245

Review 7.  Risk of breast cancer in women with breast cysts.

Authors:  J E Devitt; T To; A B Miller
Journal:  CMAJ       Date:  1992-07-01       Impact factor: 8.262

8.  Intraductal apocrine carcinoma: a clinicopathologic study of 37 cases.

Authors:  F A Tavassoli; H J Norris
Journal:  Mod Pathol       Date:  1994-10       Impact factor: 7.842

9.  Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies.

Authors:  M Nielsen; J L Thomsen; S Primdahl; U Dyreborg; J A Andersen
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

10.  Is there an increased risk of breast cancer in women who have had a breast cyst aspirated?

Authors:  N J Bundred; R R West; J O Dowd; R E Mansel; L E Hughes
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

View more
  13 in total

1.  Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients.

Authors:  Neil Fuehrer; Lynn Hartmann; Amy Degnim; Teresa Allers; Robert Vierkant; Marlene Frost; Daniel Visscher
Journal:  Arch Pathol Lab Med       Date:  2012-02       Impact factor: 5.534

2.  Apocrine Metaplasia in Intraductal Papilloma with Foci of DCIS: A Friend or Foe?

Authors:  Debjani Mallick; Aniruna Aniruna; Sonia Gon; Gayatri Ghosh
Journal:  Iran J Pathol       Date:  2016

Review 3.  [Diagnostics of benign ductal epithelial cell proliferation of the breast in biopsy material].

Authors:  H-P Sinn; C Flechtenmacher; S Aulmann
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

Review 4.  Androgens in human breast carcinoma.

Authors:  Takashi Suzuki; Yasuhiro Miki; Kiyoshi Takagi; Hisashi Hirakawa; Takuya Moriya; Noriaki Ohuchi; Hironobu Sasano
Journal:  Med Mol Morphol       Date:  2010-08-04       Impact factor: 2.309

5.  High level PHGDH expression in breast is predominantly associated with keratin 5-positive cell lineage independently of malignancy.

Authors:  Irina Gromova; Pavel Gromov; Naoko Honma; Sudha Kumar; David Rimm; Maj-Lis Møller Talman; Vera Timmermans Wielenga; José M A Moreira
Journal:  Mol Oncol       Date:  2015-05-14       Impact factor: 6.603

6.  Encapsulated apocrine papillary carcinoma of the breast--a tumour of uncertain malignant potential: report of five cases.

Authors:  Melanie Seal; Christine Wilson; Gregory J Naus; Stephen Chia; Terry C Bainbridge; Malcolm M Hayes
Journal:  Virchows Arch       Date:  2009-10-28       Impact factor: 4.064

7.  Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.

Authors:  Julio E Celis; Teresa Cabezón; José M A Moreira; Pavel Gromov; Irina Gromova; Vera Timmermans-Wielenga; Takuji Iwase; Futoshi Akiyama; Naoko Honma; Fritz Rank
Journal:  Mol Oncol       Date:  2009-02-03       Impact factor: 6.603

8.  Mixed Mucinous and Infiltrating Carcinoma Occurring in Male Breast- Study of Clinico-Pathological Features: A Rare Case Report.

Authors:  Kavita Gupta; Swati Sharma; Ranjini Kudva; Sandeep Kumar
Journal:  J Clin Diagn Res       Date:  2015-06-01

9.  Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.

Authors:  Trine Tramm; Jee-Yeon Kim; Sebastian Leibl; Farid Moinfar; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2016-06-10       Impact factor: 4.064

10.  Non-operative breast pathology.

Authors:  Sarah E Pinder; Jorge S Reis-Filho
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.